Abidi A - Search Results

1

Preclinical evaluation of SMM-189, a cannabinoid receptor 2-specific inverse agonist.

Presley C, Abidi A, Suryawanshi S, Mustafa S, Meibohm B, Moore BM. Presley C, et al. Among authors: abidi a. Pharmacol Res Perspect. 2015 Aug;3(4):e00159. doi: 10.1002/prp2.159. Epub 2015 Jul 6. Pharmacol Res Perspect. 2015. PMID: 26196013 Free PMC article.

2

Mechanism of anti-glioma activity and in vivo efficacy of the cannabinoid ligand KM-233.

Gurley SN, Abidi AH, Allison P, Guan P, Duntsch C, Robertson JH, Kosanke SD, Keir ST, Bigner DD, Elberger AJ, Moore BM 2nd. Gurley SN, et al. J Neurooncol. 2012 Nov;110(2):163-77. doi: 10.1007/s11060-012-0958-5. Epub 2012 Aug 9. J Neurooncol. 2012. PMID: 22875710

3

Synthesis and biological evaluation of (3',5'-dichloro-2,6-dihydroxy-biphenyl-4-yl)-aryl/alkyl-methanone selective CB2 inverse agonist.

Presley CS, Mustafa SM, Abidi AH, Moore BM 2nd. Presley CS, et al. Bioorg Med Chem. 2015 Sep 1;23(17):5390-401. doi: 10.1016/j.bmc.2015.07.057. Epub 2015 Jul 29. Bioorg Med Chem. 2015. PMID: 26275680

4

Cannabinoid receptor 1 ligands revisited: Pharmacological assessment in the ACTOne system.

Presley CS, Abidi AH, Moore BM 2nd. Presley CS, et al. Anal Biochem. 2016 Apr 1;498:8-28. doi: 10.1016/j.ab.2015.12.019. Epub 2016 Jan 7. Anal Biochem. 2016. PMID: 26772161

5

Corrigendum to 'Cannabinoid receptor 1 ligands revisited: Pharmacological assessment in the ACTOne system' [Analytical Biochemistry 498 (2016) 8-28].

Presley CS, Abidi AH, Moore BM 2nd. Presley CS, et al. Anal Biochem. 2016 May 15;501:47. doi: 10.1016/j.ab.2016.03.002. Epub 2016 Mar 15. Anal Biochem. 2016. PMID: 27064120 No abstract available.

6

Optimization of cAMP fluorescence dataset from ACTOne cannabinoid receptor 1 cell line.

Presley CS, Abidi AH, Moore BM 2nd. Presley CS, et al. Data Brief. 2016 Apr 1;7:1118-23. doi: 10.1016/j.dib.2016.03.086. eCollection 2016 Jun. Data Brief. 2016. PMID: 27115025 Free PMC article.

7

Anti-inflammatory activity of cannabinoid receptor 2 ligands in primary hPDL fibroblasts.

Abidi AH, Presley CS, Dabbous M, Tipton DA, Mustafa SM, Moore BM 2nd. Abidi AH, et al. Arch Oral Biol. 2018 Mar;87:79-85. doi: 10.1016/j.archoralbio.2017.12.005. Epub 2017 Dec 6. Arch Oral Biol. 2018. PMID: 29274621

8

Cannabinoid type-2 receptor agonist, inverse agonist, and anandamide regulation of inflammatory responses in IL-1β stimulated primary human periodontal ligament fibroblasts.

Abidi AH, Alghamdi SS, Dabbous MK, Tipton DA, Mustafa SM, Moore BM. Abidi AH, et al. J Periodontal Res. 2020 Oct;55(5):762-783. doi: 10.1111/jre.12765. Epub 2020 Jun 20. J Periodontal Res. 2020. PMID: 32562275

9

Phytocannabinoids regulate inflammation in IL-1β-stimulated human gingival fibroblasts.

Abidi AH, Abhyankar V, Alghamdi SS, Tipton DA, Dabbous M. Abidi AH, et al. J Periodontal Res. 2022 Dec;57(6):1127-1138. doi: 10.1111/jre.13050. Epub 2022 Sep 7. J Periodontal Res. 2022. PMID: 36070347

10

Immunomodulatory activity seen as a result of photobiomodulation therapy in stimulated primary human fibroblasts.

Abidi AH, Mayall RE, Ruan CX, Ou KL, Walinski CJ. Abidi AH, et al. Arch Oral Biol. 2021 Jan;121:104968. doi: 10.1016/j.archoralbio.2020.104968. Epub 2020 Nov 7. Arch Oral Biol. 2021. PMID: 33221565

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

111 results

Search Page

Filters